BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Topics
»
Regulatory
» EMA
EMA
RSS
Myrcludex B granted EMA PRIME eligibility
May 26, 2017
EMA awards orphan drug designation to Actinium's Actimab-A
May 25, 2017
EMA committee recommends orphan drug designation for MK-0677
May 25, 2017
FDA and EMA accept submissions for UX-003 for mucopolysaccharidosis VII
May 24, 2017
EMA grants orphan drug designation to avacopan for C3 glomerulopathy
May 24, 2017
EMA committee recommends approval of Oxervate for neurotrophic keratitis
May 23, 2017
EMA committee gives positive opinion to brodalumab for plaque psoriasis
May 23, 2017
Cariprazine granted positive opinion in Europe for the treatment of schizophrenia
May 23, 2017
Cardioxane receives positive CHMP opinion in Europe
May 22, 2017
Articular cartilage product granted positive opinion from CHMP for European approval
May 22, 2017
Previous
1
2
…
40
41
42
43
44
45
46
47
48
…
158
159
Next
RSS